Some questions about the first decision of the Belgian court in the dispute between AstraZeneca and the European Commission

In the dispute between AstraZeneca and European Commission, the Belgian Court does not mention (in point IV. A. of the Decision) art. 25 of Regulation (EU) 1215/2012 Of the European Parliament and of the Council. This article states that “[i]f the parties, regardless of their domicile, have agreed that a court or the courts ofContinue reading “Some questions about the first decision of the Belgian court in the dispute between AstraZeneca and the European Commission”

Force majeure under the “European Commission-AstraZeneca and European Commission-Curevac” contracts

(See more: https://cisg-online.org/Home/international-sales-law-news/force-majeure-under-the-european-commission-astrazeneca-and-european-commission-curevac-contracts)

Decision of the French Court of Cassation

03 February 2021 Summary: Pursuant to Article 39 of the United Nations Convention on Contracts for the International Sale of Goods of 11 April 1980 (CISG), a buyer is deprived of the right to rely on a lack of conformity if he does not report it within two years from the date on which theContinue reading “Decision of the French Court of Cassation”

Decision of the Portuguese Supreme Court

Article 75 and Article 76 CISG cited in a decision of the Portuguese Supreme Court of Justice after the accession of Portugal to the Convention (see more) Artigos 75 e 76 da Convenção de Viena sobre a Venda Internacional de Mercadorias citada em Acórdão do Supremo Tribunal de Justiça após adesão de Portugal (ver mais)

New CISG Advisory Council Opinion

CISG Advisory Council Opinion No. 21Delivery of Substitute Goods and Repair under the CISG To be cited as: CISG-AC Opinion No. 21, Delivery of Substitute Goods and Repair under the CISG, Rapporteurs: Professor (em.) Dr. Ingeborg Schwenzer, LL.M., University of Basel, Switzerland, and Dr. Ilka H. Beimel, Germany. Adopted unanimously by the CISG Advisory CouncilContinue reading “New CISG Advisory Council Opinion”